Johnson Matthey Pharmaceutical Materials
Our United Kingdom-based parent company, Johnson Matthey PLC, is a world leader in advanced materials technology, and has been a prime global player in the industry for more than 180 years.
With our New Jersey facilities, the group manufactures pharmaceutical compounds and active bulk intermediates; the facility specializes in the manufacture of controlled substances and anti-cancer bulk pharmaceuticals.
Johnson Matthey Pharmaceuticals draws on the substantial technical resources of the Johnson Matthey Group, which spent £35 Million on Research and Development last year. We seek partnerships with our customers in developing new products and we apply the latest technology in meeting and exceeding our customer's needs.